Eli Lilly and Company (LLY), Amylin Pharmaceuticals, Inc. (AMLN) Diabetes Drug Linked to Two Deaths; FDA To Strengthen Warnings
8/19/2008
WASHINGTON (Reuters) - U.S. health regulators warned of more cases of dangerous pancreas inflammation in patients taking Amylin Pharmaceuticals Inc's diabetes drug, Byetta, pounding company shares on fears of lower sales and doubts about a new version of the medicine.